Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn’s Disease: Results from the Phase 2 Open-Label Extension StudyOriginal Article Published on 2021-12-022024-09-04 Journal: Journal of Crohn's and Colitis [Category] 대상포진, [키워드] Crohn’s disease long-term safety Open-label extension [DOI] 10.1093/ecco-jcc/jjab093 PMC 바로가기 [Article Type] Original Article
Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years’ follow-upClinical Science Published on 2020-02-152024-09-04 Journal: Rheumatology (Oxford, England) [Category] 대상포진, [키워드] biologic DMARD IL-6 inhibition integrated safety analysis long-term safety sarilumab [DOI] 10.1093/rheumatology/kez265 PMC 바로가기 [Article Type] Clinical Science
Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naïve patients with chronic hepatitis BReview Published on 2017-03-012023-06-17 Journal: Current medical research and opinion [Category] B형 간염, [키워드] Chronic Hepatitis B long-term benefits long-term safety Nucleoside analogues nucleotide analogues outcomes [DOI] 10.1080/03007995.2016.1264932 [Article Type] Review